FdaApplication

NDA 020780

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBAYER HEALTHCARE PHARMACEUTICALS INC
application_typeNDA
approval_date1997-09-26

Products (2)

ProductActive ingredientStrengthDosage form
CIPROCIPROFLOXACIN250MG/5MLFOR SUSPENSION;ORAL
CIPROCIPROFLOXACIN500MG/5MLFOR SUSPENSION;ORAL

2 products